Literature DB >> 15706344

The validity of the SRS-22 instrument in an adult spinal deformity population compared with the Oswestry and SF-12: a study of response distribution, concurrent validity, internal consistency, and reliability.

Keith H Bridwell1, William Cats-Baril, John Harrast, Sigurd Berven, Steven Glassman, Jean-Pierre Farcy, William C Horton, Lawrence G Lenke, Christine Baldus, Terri Radake.   

Abstract

STUDY
DESIGN: Prospective analysis of a consecutive cohort of adult spinal deformity patients queried over a 12-month period.
OBJECTIVES: To assess the SRS-22 instrument compared with the SF-12 and Oswestry. SUMMARY OF BACKGROUND DATA: Very few reports in the literature have applied the SRS-22 to adult spinal deformity patients.
METHODS: Consecutive adult spinal deformity patients were applied the SRS-22, SF-12, and Oswestry. Four analyses were done: 1) floor/ceiling effect; 2) Pearson's correlation coefficients between the SRS-22, SF-12, and Oswestry; 3) Cronbach's alpha analysis for internal consistency within the SRS-22; and 4) test/retest.
RESULTS: Floor/ceiling range for the SRS-22 compared favorably with the SF-12 and Oswestry. The Pearson's coefficients correlating the two questionnaires relative to the SRS-22 were > 0.7. The Cronbach's alpha within each domain for the SRS-22 were > 0.7, except for pain (0.67). Test/retest correlation coefficients ranged from 0.84 to 0.95 for the subscales.
CONCLUSIONS: The SRS-22 is a disease-specific instrument with the capacity to demonstrate change in health status more effectively than the SF-12 and in more domains than the Oswestry. The SRS-22 showed high criterion validity with the SF-12 and Oswestry based on Pearson's coefficients. High Cronbach's alpha scores suggested a high internal consistency within each domain of the SRS-22, except for pain (0.67). Test/retest reliability was excellent.

Entities:  

Mesh:

Year:  2005        PMID: 15706344     DOI: 10.1097/01.brs.0000153393.82368.6b

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  23 in total

1.  Likelihood of reaching minimal clinically important difference in adult spinal deformity: a comparison of operative and nonoperative treatment.

Authors:  Shian Liu; Frank Schwab; Justin S Smith; Eric Klineberg; Christopher P Ames; Gregory Mundis; Richard Hostin; Khaled Kebaish; Vedat Deviren; Munish Gupta; Oheneba Boachie-Adjei; Robert A Hart; Shay Bess; Virginie Lafage
Journal:  Ochsner J       Date:  2014

2.  Impact of adult spinal deformity corrective surgery in patients with the symptoms of gastroesophageal reflux disease: a 5-year follow-up report.

Authors:  Tomohiko Hasegawa; Hiroki Ushirozako; Yu Yamato; Daisuke Togawa; Go Yoshida; Sho Kobayashi; Tatsuya Yasuda; Tomohiro Banno; Hideyuki Arima; Shin Oe; Tomohiro Yamada; Koichiro Ide; Yuh Watanabe; Yukihiro Matsuyama
Journal:  Eur Spine J       Date:  2020-01-25       Impact factor: 3.134

3.  Adult spinal deformity surgical decision-making score : Part 1: development and validation of a scoring system to guide the selection of treatment modalities for patients below 40 years with adult spinal deformity.

Authors:  Takashi Fujishiro; Louis Boissière; Derek Thomas Cawley; Daniel Larrieu; Olivier Gille; Jean-Marc Vital; Ferran Pellisé; Francisco Javier Sanchez Pérez-Grueso; Frank Kleinstück; Emre Acaroglu; Ahmet Alanay; Ibrahim Obeid
Journal:  Eur Spine J       Date:  2019-03-07       Impact factor: 3.134

4.  Adult spinal deformity surgical decision-making score. Part 2: development and validation of a scoring system to guide the selection of treatment modalities for patients above 40 years with adult spinal deformity.

Authors:  Takashi Fujishiro; Louis Boissière; Derek Thomas Cawley; Daniel Larrieu; Olivier Gille; Jean-Marc Vital; Ferran Pellisé; Francisco Javier Sanchez Pérez-Grueso; Frank Kleinstück; Emre Acaroglu; Ahmet Alanay; Ibrahim Obeid
Journal:  Eur Spine J       Date:  2019-07-17       Impact factor: 3.134

Review 5.  Measuring outcomes in adult spinal deformity surgery: a systematic review to identify current strengths, weaknesses and gaps in patient-reported outcome measures.

Authors:  Sayf S A Faraj; Miranda L van Hooff; Roderick M Holewijn; David W Polly; Tsjitske M Haanstra; Marinus de Kleuver
Journal:  Eur Spine J       Date:  2017-05-22       Impact factor: 3.134

6.  Does Clinical Photography Influence Satisfaction With Surgery in Adult Patients Operated on for Spinal Deformity?

Authors:  Alejandro Gomez-Rice; Cristina Madrid; Enrique Izquierdo; Fernando Marco-MartÍnez; JesÚs A F Tresguerres; Felisa Sanchez-Mariscal
Journal:  Int J Spine Surg       Date:  2020-12-29

7.  The Core Outcome Measures Index (COMI) is a responsive instrument for assessing the outcome of treatment for adult spinal deformity.

Authors:  A F Mannion; A Vila-Casademunt; M Domingo-Sàbat; S Wunderlin; F Pellisé; J Bago; E Acaroglu; A Alanay; F S Pérez-Grueso; I Obeid; F S Kleinstück
Journal:  Eur Spine J       Date:  2015-10-30       Impact factor: 3.134

8.  Factors affecting the outcome in appearance of AIS surgery in terms of the minimal clinically important difference.

Authors:  James T Bennett; Amer F Samdani; Tracey P Bastrom; Robert J Ames; Firoz Miyanji; Joshua M Pahys; Michelle C Marks; Baron S Lonner; Peter O Newton; Harry L Shufflebarger; Burt Yaszay; John M Flynn; Randal R Betz; Patrick J Cahill
Journal:  Eur Spine J       Date:  2016-12-09       Impact factor: 3.134

9.  Minimal important differences of the SRS-22 Patient Questionnaire following surgical treatment of idiopathic scoliosis.

Authors:  Juan Bagó; Francisco J S Pérez-Grueso; Esther Les; Pablo Hernández; Ferran Pellisé
Journal:  Eur Spine J       Date:  2009-06-16       Impact factor: 3.134

10.  Reliability of the revised Scoliosis Research Society-22 and Oswestry Disability Index (ODI) questionnaires in adult spinal deformity when administered by telephone.

Authors:  Steven L Bokshan; Jakub Godzik; Jonathan Dalton; Jennifer Jaffe; Lawrence G Lenke; Michael P Kelly
Journal:  Spine J       Date:  2016-03-17       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.